Streetbeat News

Regulatory

IMMX

The U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to Immix Biopharma's NXC-201 for the treatment of multiple myeloma. The designation qualifies NXC-201 for 7 years of U.S. market exclusivity after approval, tax credits for qualified clinical testing, and a waiver of the Prescription Drug User Fee. The multiple myeloma market, valued at $13.9 billion in 2017, is expected to reach $28.7 billion in 2027.

Portfolio Pulse from Happy Mohamed

August 23, 2023 | 12:39 pm

LBPH

Longboard Pharmaceuticals, Inc. (NASDAQ:LBPH) has completed enrollment for its Phase 1b/2a clinical trial, the PACIFIC Study, which is evaluating LP352 for the treatment of Developmental and Epileptic Encephalopathies (DEEs). The study has enrolled 52 participants and aims to assess the safety and tolerability of LP352. Topline results are expected around year-end 2023.

Portfolio Pulse from Happy Mohamed

August 23, 2023 | 12:31 pm

ADIL

Adial Pharmaceuticals has regained compliance with Nasdaq's listing requirements, thereby avoiding potential delisting.

Portfolio Pulse from Benzinga Newsdesk

August 23, 2023 | 12:31 pm

WRNT

Warrantee has received a notification of deficiency from Nasdaq due to its failure to timely file its annual report on Form 20-F.

Portfolio Pulse from Benzinga Newsdesk

August 23, 2023 | 12:17 pm

NDRA

ENDRA Life Sciences has been issued three new patents in the U.S. and Europe, strengthening the proprietary position of its TAEUS system. The patents relate to a novel radio frequency applicator, a method and system for monitoring tissue temperature during surgical procedures, and a method and system for determining fractional fat content of tissue. The company's portfolio now includes 67 issued patents globally.

Portfolio Pulse from Benzinga Newsdesk

August 23, 2023 | 12:09 pm

VRNOF

Verano Holdings Corp. (CSE:VRNO) (OTCQX:VRNOF) has sued the Alabama Medical Cannabis Commission (AMCC) over the revocation and re-awarding of its Integrated Facility License. Verano initially secured the license in June but lost it in August when the AMCC chose Insa Alabama LLC instead. Verano argues that the commission's actions exceed its statutory authority. The AMCC plans to redo its licensing process again on Aug. 31.

Portfolio Pulse from Jelena Martinovic

August 23, 2023 | 12:07 pm

ABNB

BKNG

New York City's stricter short-term rental regulations have led to a significant decline in Airbnb, Inc (NYSE:ABNB) listings. The new rules, which come into effect on September 5, require hosts to register with the city and be present during guests' stays. Airbnb has blocked future bookings post this timeline. The regulations could also impact other platforms like Vrbo and Booking.com (NASDAQ:BKNG) as they could face penalties for processing payments for unregistered transactions.

Portfolio Pulse from Anusuya Lahiri

August 23, 2023 | 12:03 pm

CHDN

Churchill Downs Incorporated (CDI) has received approval from the Kentucky Horse Racing Commission for temporary licenses for six of its properties. These licenses will allow the properties to start accepting in-person sports wagers from September 7.

Portfolio Pulse from Benzinga Newsdesk

August 23, 2023 | 12:03 pm

WINT

Windtree Therapeutics has been issued a Composition of Matter patent for Dual Mechanism SERCA2a Activators by the US Patent and Trademark Office. This patent will provide protection for the company's SERCA2a activator technology.

Portfolio Pulse from Benzinga Newsdesk

August 23, 2023 | 12:02 pm

MNK

Trading of Mallinckrodt's shares has been halted due to pending news.

Portfolio Pulse from Benzinga Newsdesk

August 23, 2023 | 12:01 pm